Femara Helps Protect Against Return Of Breast Cancer Even When Treatment Starts Several Years After Completing Tamoxifen Therapy
Women may reduce the risk of their breast cancer returning by starting treatment with Femara® (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology1.
More: continued here
Filed under: Breast Cancer on March 14th, 2008